Wellumio closes an oversubscribed $9.75 million Pre-Series A round led by Nuance Connected Capital to accelerate its portable stroke imaging technology.
Amount Raised
NZ$9.75 Million
Round Type
Pre-Series A
Investors
Description
Wellumio, a New Zealand medtech company, has raised $9.75 million in a Pre-Series A funding round. This round will help expand their team and advance clinical and product development for their Axana® brain imaging device. The investment was led by Nuance Connected Capital and included participation from various international investors. The funding aims to support clinical evaluation across additional sites and geographies.
Quick answer
Wellumio raised NZ$9.75 Million in a Pre-Series A round, dated July 24, 2026. Investors: Flying Kiwi, Cure Kids Ventures, Nz Growth Capital Partners (Nzgcp)’S Aspire Seed Fund, Booster, Pacific Channel, Icehouse Ventures, Jumpspace Ventures and Bioshore Ventures. Wellumio is based in Wellington, Wellington, New Zealand.
- How much did Wellumio raise?
- Wellumio raised NZ$9.75 Million in a Pre-Series A round on July 24, 2026.
- Who invested in Wellumio?
- Flying Kiwi, Cure Kids Ventures, Nz Growth Capital Partners (Nzgcp)’S Aspire Seed Fund, Booster, Pacific Channel, Icehouse Ventures, Jumpspace Ventures and Bioshore Ventures are named as investors in this round.
- What does Wellumio do?
- Wellumio is a New Zealand medtech company developing a portable stroke detection device called Axana.
- Where is Wellumio based and how big is it?
- Wellumio is based in Wellington, Wellington, New Zealand. Fundz records about 16 employees.
- Who are the decision-makers at Wellumio?
- Fundz holds 2 contacts at Wellumio, including the Chief Commercial Officer & Executive Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Wellumio that raised within 45 days of this round, from Fundz verified event records.
- Seraxis raised $10M on September 7, 2026.
- Simnova Biotech raised $60M (Series B) on September 6, 2026.
- Hi Rasmus raised $50M on September 6, 2026.
- Superluminal Medicines raised $60M (Series B) on September 6, 2026.
- Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
- Tensive S.r.l raised $23M (Debt Financing) on September 3, 2026.
Who to call at Wellumio, and when
A new round usually means Wellumio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Wellumio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Wellumio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Wellumio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Wellumio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Wellumio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.